Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist
Why this trial matters: First large Phase III evidence of biopsy-confirmed histologic benefit with a metabolic drug in MASH Demonstrates semaglutides impact beyond weight loss to disease-modifying liver effects Supports expanding GLP-1 therapeutics into liver disease care amid a high unmet need Ianalumab Meets Endpoints in Phase III Sjgrens Disease Trials (NEPTUNUS-1 & 2) Novartis reported that both Phase III studies of ianalumab achieved their primary endpoints in patients with Sjgrens disease, offering the first targeted therapy with statistically significant disease activity reduction in this chronic autoimmune disorder
Additional Ingredients Capsule Shell : Hydroxypropyl Methylcellulose : Used to form the capsule, making it easy to swallow
Whether you are looking to improve your sleep, boost your energy, or simply support your long-term cellular health, we are here to provide the tools you need
The National Institutes of Health describes this as the bodys weight-defense system, a built-in survival response meant to protect you from starvation
The choice between the two depends on whether research goals prioritize skin pigmentation, appetite regulation, or sexual function
